Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tepotinib in NSCLC patients with METex14 mutations: Interim results from the phase II VISION study
    Meeting Abstract

    Sakai, H.; Veillon, R.; Cortot, A. B.; Felip, E.; Mazieres, J.; Morise, M.; Sakamoto, T.; Tokito, T.; Atagi, S.; Kato, T.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Five-year overall survival for patients with advanced non-small-cell lung cancer treated with pembrolizumab: Results from the phase I KEYNOTE-001 study
    Journal Article

    Garon, E. B.; Hellmann, M. D.; Rizvi, N. A.; Carcereny, E.; Leighl, N. B.; Ahn, M. J.; Eder, J. P.; Balmanoukian, A. S.; Aggarwal, C.; Horn, L.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Resistance to TRK inhibition mediated by convergent MAPK pathway activation
    Research Letter

    Cocco, E.; Schram, A. M.; Kulick, A.; Misale, S.; Won, H. H.; Yaeger, R.; Razavi, P.; Ptashkin, R.; Hechtman, J. F.; Toska, E.; more...
    Nature Medicine (2019)

    Fulltext@MSK | Save
  • A novel acquired exon 20 EGFR M766Q mutation in lung adenocarcinoma mediates osimertinib resistance but is sensitive to neratinib and poziotinib
    Journal Article

    Castellano, G. M.; Aisner, J.; Burley, S. K.; Vallat, B.; Yu, H. A.; Pine, S. R.; Ganesan, S.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Prevalence and preliminary validation of screening criteria to identify carriers of germline BAP1 mutations
    Journal Article

    Zauderer, M. G.; Jayakumaran, G.; DuBoff, M.; Zhang, L.; Francis, J. H.; Abramson, D. H.; Cercek, A.; Nash, G. M.; Shoushtari, A.; Chapman, P.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Five-year survival and correlates among patients with advanced melanoma, renal cell carcinoma, or non-small cell lung cancer treated with nivolumab
    Journal Article

    Topalian, S. L.; Hodi, F. S.; Brahmer, J. R.; Gettinger, S. N.; Smith, D. C.; McDermott, D. F.; Powderly, J. D.; Sosman, J. A.; Atkins, M. B.; Leming, P. D.; more...
    JAMA Oncology (2019)

    Fulltext@MSK | Save
  • Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: A pooled analysis
    Journal Article

    Antonia, S. J.; Borghaei, H.; Ramalingam, S. S.; Horn, L.; De Castro Carpeño, J.; Pluzanski, A.; Burgio, M. A.; Garassino, M.; Chow, L. Q. M.; Gettinger, S.; more...
    Lancet Oncology (2019)

    Fulltext@MSK | Save
  • Treatment outcomes of immune-related cutaneous adverse events
    Journal Article

    Phillips, G. S.; Wu, J.; Hellmann, M. D.; Postow, M. A.; Rizvi, N. A.; Freites-Martinez, A.; Chan, D.; Dusza, S.; Motzer, R. J.; Rosenberg, J. E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Circulating tumor DNA profiling in small-cell lung cancer identifies potentially targetable alterations
    Journal Article

    Devarakonda, S.; Sankararaman, S.; Herzog, B. H.; Gold, K. A.; Waqar, S. N.; Ward, J. P.; Raymond, V. M.; Lanman, R. B.; Chaudhuri, A. A.; Owonikoko, T. K.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Patterns of failure in stage IV non-small cell lung cancer patients treated with osimertinib
    Meeting Abstract

    Peoples, C.; Wang, C.; Yu, H.; Yang, T. J.; Rimner, A.; Wu, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save